Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2025-12-24 @ 11:34 PM
NCT ID:
NCT05772156
Eligibility Criteria:
Inclusion Criteria:
* Twin gestation
* Scheduled cesarean delivery (\>=34 weeks)
Exclusion criteria:
* Patients with known hypertensive disease: history of chronic hypertension, gestational hypertension or preeclampsia with or without severe features
* Use of protease inhibitors given known vasoconstrictive side effects with concomitant methylergonovine administration
* Hypersensitivity to methylergonovine or any of the ingredients
* Participating in another intervention study where the primary outcome includes postpartum bleeding or thromboembolism, or the study intervention directly affects postpartum bleeding or thromboembolism
* Receipt of uterotonics, other than oxytocin, or planned or expected use of uterotonic prophylaxis
* Non-elective cesarean delivery
Healthy Volunteers:
False
Sex:
FEMALE
Maximum Age:
65 Years
Study:
NCT05772156
Study Brief:
Protocol Section:
NCT05772156